Aislinn Antrim, Managing Editor

The findings provide an alternative delivery strategy for peptide-based drugs and suggest that such techniques and principles could be applied to a broader range of drugs.

The report highlights the growth of personalized medicines with improved efficacy for rare, previously untreatable diseases.

The protein, called suPAR, has long been known to be a biomarker for poor outcomes and disease progression in both kidney disease and cardiovascular disease.

The changes will almost certainly widen access for patients seeking medicated abortions in states without legal obstacles.

Owning your time and scheduling self check-ins can help students avoid burnout.

Pharmacists can play a critical role in this therapy, panelists in a recent Pharmacy Times® Peer Exchange say.

Investigators have found that the evolutionary sequence of insulin has become stuck at the edge of impaired production, limiting its ability to adapt to obesity and rendering most people vulnerable to type 2 diabetes.

In voting in favor of the recommendation, 22 committee members unanimously agreed that the benefits of the Johnson & Johnson COVID-19 vaccine outweigh its risks.

A panel of experts discusses alert systems, surface contamination, and PPE as methods for minimizing exposure to dispensing pharmacists.

As the COVID-19 pandemic continues, pharmacists and other health care professionals have had to contend simultaneously with the continuing substance use epidemic.

Although study results show that substitution rates for most drug classes exceeded 90%, some were as low as 64%.

In response to high demand for the unproven COVID-19 treatments, chloroquine and hydroxychloroquine, the FDA has issued 2 product-specific guidance documents for manufacturers.

In response to the financial crisis driven by the coronavirus disease 2019 (COVID-19) pandemic, drug manufacturers are aiming to increase access to insulin products.

California has passed SB 159, becoming the first state allowing pharmacists to dispense HIV prevention pills to patients without a doctor’s prescription. Supporters say the legislation will greatly reduce the spread of infection.1

Stay tuned for upcoming coverage on the NACDS Total Store Expo in Boston, MA, August 24-26.

An FDA committee has recommended approval of Gilead’s Descovy to reduce the risk of sexually acquired HIV infection in those at high risk of acquiring the virus.

By counseling patients on over-the-counter (OTC) options when appropriate and carrying durable medical equipment (DME) such as walking aids and compression socks, pharmacists can expand their range of care and bring in more customers.

Attendees at the McKesson ideaShare had the chance to hear about women pharmacists and the challenges, successes, and opportunities they have in a session presented by Suzanne Soliman, PharmD.

Improving health, maintaining health, or supplementing a child’s diet are all common reasons to recommend vitamins for some children, said Marsha Millonig, BSPharm, in a session at the McKesson ideaShare on Wednesday.

Allan Fettig and Aaron Finley, co-owners of Trumm Drug and recipients of the 2019 Health Mart Pharmacy of the Year Award, discuss how they went about taking ownership of the pharmacy in April 2018.

Travel health services involves a lot more than vaccinations, said Sheri Stensland, PharmD, in a session at McKesson ideaShare.

Tera Moore, PharmD, discusses key strategies for successfully integrating psychiatric pharmacist providers in mental healthcare teams.

Tom Kraus, of ASHP, says pharmacists should play an active role in advocating for policy changes and legislative actions.

Tom Kraus, VP of Government Relations for ASHP, discusses what they're focusing on regarding drug pricing legislation.